Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DNA - Ginkgo Bioworks Holdings, Inc.

Close
9.36
0.580   6.197%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:22:24 PM CET

PREVIOUS CLOSE
CHG
CHG%
$8.78
0.58
6.61%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.04%
1 Month
15.11%
3 Months
20.75%
6 Months
2,828.13%
1 Year
435.43%
2 Year
464.46%
Key data
Stock price
$9.36
P/E Ratio 
-12.85
DAY RANGE
$8.78 - $9.59
EPS 
-$0.45
52 WEEK RANGE
$0.24 - $11.98
52 WEEK CHANGE
$429.38
MARKET CAP 
11.534 B
YIELD 
N/A
SHARES OUTSTANDING 
1.724 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,661,389
AVERAGE 30 VOLUME 
$1,450,251
Company detail
CEO: Jason Kelly
Region: US
Website: ginkgobioworks.com
Employees: 640
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.

Recent news